CMPD-1

A substrate-selective p38α MAPK inhibitor

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
10mg

￥2175.00

1740.00

- +
50mg

￥7450.00

5960.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajci6602
CAS: 41179-33-3
别名: CMPD 1
分子式: C22H20FNO2
分子量: 349.4
纯度: >98%
溶解度: <34.94mg/ml in DMSO; <34.94mg/ml in ethanol
储存: Store at RT
库存: 现货

Background

CMPD1 is a selective and non-ATP-competitive p38 MAPK-mediated MK2 phosphorylation inhibitor with apparent Ki (Kiapp) of 330?nM[1][2].

CMPD1 does not inhibit p38 MAPK-mediated phosphorylation of other two substrates, MBP and ATF2[1].CMPD1 induced mitotic arrest and apoptosis in U87 cells[1].CMPD1 inhibits tubulin polymerisation in glioblastoma cells[3].

参考文献:
[1]. Gurgis F, et al. Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2. Cell Death Discov. 2015 Sep 7;1:15028.
[2]. Davidson W, er al. Discovery and characterization of a substrate selective p38alpha inhibitor. Biochemistry. 2004 Sep 21;43(37):11658-71.
[3]. Phoa AF, et al. Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling. Biochem Pharmacol. 2015 Dec 15;98(4):587-601.